Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 27 (fatty acid transporter), member 1 | Starlite/ChEMBL | References |
Mus musculus | solute carrier family 27 (fatty acid transporter), member 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | solute carrier family 27 (fatty acid transporter), member 1 | 646 aa | 552 aa | 22.8 % |
Mycobacterium tuberculosis | P-hydroxybenzoyl-AMP ligase FadD22 | solute carrier family 27 (fatty acid transporter), member 1 | 646 aa | 519 aa | 20.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | long-chain-acyl-CoA synthetase | 0.0231 | 1 | 1 |
Leishmania major | fatty acid transporter protein-like protein | 0.0221 | 0.954 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Trypanosoma cruzi | fatty acid transporter protein-like, putative | 0.0224 | 0.9672 | 1 |
Echinococcus granulosus | long chain fatty acid transport protein 4 | 0.0224 | 0.9672 | 1 |
Mycobacterium leprae | possible long-chain acyl-CoA synthase | 0.0221 | 0.954 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.001 | 0.001 | 1 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.001 | 0.001 | 1 |
Schistosoma mansoni | acetyl-CoA synthetase | 0.001 | 0.001 | 0.001 |
Giardia lamblia | Kinase | 0.001 | 0 | 0.5 |
Leishmania major | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Schistosoma mansoni | FFA transport protein | 0.0224 | 0.9672 | 1 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.001 | 0.001 | 0.001 |
Trypanosoma brucei | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 1 |
Giardia lamblia | Protein 21.1 | 0.001 | 0 | 0.5 |
Onchocerca volvulus | 0.001 | 0.001 | 1 | |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.001 | 0.001 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 0.001 |
Brugia malayi | acetyl-Coenzyme A synthetase 2 | 0.001 | 0.001 | 0.001 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.001 | 0.001 | 0.001 |
Leishmania major | long-chain-fatty-acid-CoA ligase, putative | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0231 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.001 | 0.001 |
Onchocerca volvulus | 0.001 | 0.001 | 1 | |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.001 | 0.001 | 0.001 |
Toxoplasma gondii | AMP-binding enzyme domain-containing protein | 0.001 | 0.001 | 1 |
Echinococcus multilocularis | long chain fatty acid transport protein 4 | 0.0224 | 0.9672 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.001 | 0.001 |
Onchocerca volvulus | 0.001 | 0.001 | 1 | |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.001 | 0.001 | 0.001 |
Echinococcus multilocularis | acetyl coenzyme A synthetase, cytoplasmic | 0.001 | 0.001 | 0.001 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | oxidoreductase | 0.001 | 0.001 | 0.001 |
Plasmodium falciparum | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.001 | 0.001 |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Leishmania major | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.001 | 0.001 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD6 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0221 | 0.954 | 1 |
Giardia lamblia | Kinase, NEK | 0.001 | 0 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Plasmodium vivax | acetyl-CoA synthetase, putative | 0.001 | 0.001 | 1 |
Entamoeba histolytica | long-chain-fatty-acid--CoA ligase, putative | 0.001 | 0.001 | 1 |
Giardia lamblia | Kinase, NEK | 0.001 | 0 | 0.5 |
Trypanosoma cruzi | fatty acid transporter protein-like, putative | 0.0224 | 0.9672 | 1 |
Onchocerca volvulus | 0.001 | 0.001 | 1 | |
Onchocerca volvulus | 0.001 | 0.001 | 1 | |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.001 | 0.001 | 1 |
Toxoplasma gondii | propionate-CoA ligase | 0.001 | 0.001 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.001 | 0.001 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.001 | 0.001 | 1 |
Echinococcus granulosus | acetyl coenzyme A synthetase cytoplasmic | 0.001 | 0.001 | 0.001 |
Trypanosoma brucei | long-chain-fatty-acid-CoA ligase, putative | 0.001 | 0.001 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.001 | 0.001 | 0.001 |
Toxoplasma gondii | Acetyl-coenzyme A synthetase 2, putative | 0.001 | 0.001 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 1 uM | Inhibition of human FLAG-tagged FATP1-mediated [1-14C] oleic acid conversion to [1-14C] oleoyl-CoA after 20 mins by scintillation counting analysis | ChEMBL. | 23528296 |
IC50 (binding) | > 10 uM | Inhibition of mouse FLAG-tagged FATP1-mediated [1-14C] oleic acid conversion to [1-14C] oleoyl-CoA after 20 mins by scintillation counting analysis | ChEMBL. | 23528296 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.